content top

Biomarkers and Predictors for Functional and Anatomic Outcomes for Pars Plana Vitrectomy and Peeling of the Internal Limiting Membrane in Naïve Diabetic Macular Edema. The VITAL Study

Posted by , , , , , , , and on Jul 13, 2018 in 08:00 - 10:00 Pediatric Retina, Trauma & Diabetic Retinopathy Session moderated by Nur Acar, Hussain Khaqan, Sengul Ozdek, Grazia Pertile & Hua Yan, 2018 EVRS Congress – Prague, 3 - Diabetic Retinopathy, 3-Saturday, September 01, 2018

ABSTRACT Aim: To evaluate the role of small gauge PPV as a first line treatment for naïve DME with a follow-up of 24 months and to investigate biomarkers and predictive factors for visual and anatomical outcome. Patients & Method: One hundred and twenty eyes, from 120 patients with a mean age of 67.0±14.9 years, were evaluated. Results: The mean baseline BCVA was 0.66 ± 0.14 logMAR, improved to 0.52 ± 0.21 logMAR after 12...

Read More

Treatment of Diabetic Macular Edema in Anti-VEGF Nonresponders. Long Time Real Life Results

Posted by , , and on Jul 11, 2018 in 08:00 – 09:30 ČOS & ČVRS Symposium, 2018 EVRS Congress – Prague, 4-Sunday, September 02, 2018

ABSTRACT Purpose: In the retrospective single center study, we evaluated the effectiveness of Dexamethasone implant (DEX) and fluocinolone acetonide (FAc) implant in patients with diabetic macular edema (DME) who insufficiently responded to anti-VEGF therapy. Methods: In total 30 eyes without improvement of best corrected visual acuity (BCVA) and central foveal thickness (CFT) after treatment with 3-14 anti-VEGF injections (ranibizumab...

Read More
content top